BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2151564)

  • 1. Effectiveness of intradermal hepatitis B immunization of hospital staff.
    McKee CM; Duke P; McEvoy MB; Kelsey MC
    Int J STD AIDS; 1990 Jan; 1(1):32-4. PubMed ID: 2151564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel--a preliminary report.
    Prasetya E; Linggadjaja W; Syambali R; Kusumo S; Dharmesetyawan DF; Rahardja U
    Ann Acad Med Singap; 1986 Apr; 15(2):153-7. PubMed ID: 2944466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(33):569-72. PubMed ID: 1830921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intradermal and intramuscular vaccination against hepatitis B.
    Bryan JP; Sjogren MH; Perine PL; Legters LJ
    Clin Infect Dis; 1992 Mar; 14(3):697-707. PubMed ID: 1532914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine.
    Weber DJ; Rutala WA; Samsa GP; Santimaw JE; Lemon SM
    JAMA; 1985 Dec; 254(22):3187-9. PubMed ID: 2933532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should individuals with anti-HBs as the only marker of infection with hepatitis B receive hepatitis B vaccine?
    MacLeod JE; MacSween HM; Warner HA; Aterman K
    Can J Public Health; 1985; 76(4):229-32. PubMed ID: 2932209
    [No Abstract]   [Full Text] [Related]  

  • 9. Intradermal hepatitis B virus vaccination for low- or non-responded health-care workers.
    Yasumura S; Shimizu Y; Yasuyama T; Hiroki O; Okada K; Tsukishiro T; Tsuchida T; Higuchi K; Watanabe A
    Acta Med Okayama; 1991 Dec; 45(6):457-9. PubMed ID: 1838229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the Centers for Disease Control. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    JAMA; 1991 Sep; 266(10):1338-9. PubMed ID: 1831865
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and side effects of low dose intradermally administered hepatitis B vaccine.
    Pathak UN; Dilawari JB; Chawla Y; Sokhey CS; Sharma BK; Ganguly NK
    Indian J Gastroenterol; 1988 Apr; 7(2):113-4. PubMed ID: 2966113
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization against hepatitis B--what can we expect? Results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B.
    Westmoreland D; Player V; Heap DC; Hammond A
    Epidemiol Infect; 1990 Jun; 104(3):499-509. PubMed ID: 2140795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of response to intramuscular versus low dose intradermal hepatitis B booster immunization.
    McKinney WP; Russler SK; Horowitz MM; Battiola RJ; Lee MB
    Infect Control Hosp Epidemiol; 1991 Apr; 12(4):226-30. PubMed ID: 1829469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine.
    Horowitz MM; Ershler WB; McKinney WP; Battiola RJ
    Ann Intern Med; 1988 Feb; 108(2):185-9. PubMed ID: 2963570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal and intramuscular route for vaccination against hepatitis B.
    González ML; Usandizaga M; Alomar P; Salvá F; Martín F; Erroz MJ; Lardinois R
    Vaccine; 1990 Aug; 8(4):402-5. PubMed ID: 2144391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of nonresponders and postexposure prophylaxis by intradermal hepatitis B vaccination in Japanese medical personnel.
    Nagafuchi S; Kashiwagi S; Okada K; Anzai K; Nakamura M; Nishimura Y; Sasazuki T; Niho Y
    JAMA; 1991 May 22-29; 265(20):2679-83. PubMed ID: 1827167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral response in health service personnel after administration of hepatitis B vaccine Gen-H-B-Vax].
    Juszczyk J; Rokossowski H; Krajewska M; Piatek A
    Przegl Epidemiol; 1991; 45(1-2):11-6. PubMed ID: 1839075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy.
    Redfield RR; Innis BL; Scott RM; Cannon HG; Bancroft WH
    JAMA; 1985 Dec; 254(22):3203-6. PubMed ID: 2933535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.